Convalescent Plasma as a Possible Treatment for COVID-19
Clinical trial NCT04442191 · RECRUITING
Trial details
- NCT number
- NCT04442191
- Sponsor
- University of Illinois at Chicago
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-05
- Primary completion
- 2021-05-05
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.